These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 16456093

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Ertiprotafib improves glycemic control and lowers lipids via multiple mechanisms.
    Erbe DV, Wang S, Zhang YL, Harding K, Kung L, Tam M, Stolz L, Xing Y, Furey S, Qadri A, Klaman LD, Tobin JF.
    Mol Pharmacol; 2005 Jan; 67(1):69-77. PubMed ID: 15475571
    [Abstract] [Full Text] [Related]

  • 45. Evolution of peroxisome proliferator-activated receptor agonists.
    Chang F, Jaber LA, Berlie HD, O'Connell MB.
    Ann Pharmacother; 2007 Jun; 41(6):973-83. PubMed ID: 17519293
    [Abstract] [Full Text] [Related]

  • 46. PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression.
    Hulsmans M, Geeraert B, Arnould T, Tsatsanis C, Holvoet P.
    PLoS One; 2013 Jun; 8(4):e62253. PubMed ID: 23620818
    [Abstract] [Full Text] [Related]

  • 47. Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice.
    Geeraert B, Crombé F, Hulsmans M, Benhabilès N, Geuns JM, Holvoet P.
    Int J Obes (Lond); 2010 Mar; 34(3):569-77. PubMed ID: 20010904
    [Abstract] [Full Text] [Related]

  • 48. P633H, a novel dual agonist at peroxisome proliferator-activated receptors alpha and gamma, with different anti-diabetic effects in db/db and KK-Ay mice.
    Chen W, Zhou XB, Liu HY, Xu C, Wang LL, Li S.
    Br J Pharmacol; 2009 Jul; 157(5):724-35. PubMed ID: 19422369
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Design and synthesis of dual peroxisome proliferator-activated receptors gamma and delta agonists as novel euglycemic agents with a reduced weight gain profile.
    Xu Y, Etgen GJ, Broderick CL, Canada E, Gonzalez I, Lamar J, Montrose-Rafizadeh C, Oldham BA, Osborne JJ, Xie C, Shi Q, Winneroski LL, York J, Yumibe N, Zink R, Mantlo N.
    J Med Chem; 2006 Sep 21; 49(19):5649-52. PubMed ID: 16970391
    [Abstract] [Full Text] [Related]

  • 51. The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.
    Mazzucotelli A, Viguerie N, Tiraby C, Annicotte JS, Mairal A, Klimcakova E, Lepin E, Delmar P, Dejean S, Tavernier G, Lefort C, Hidalgo J, Pineau T, Fajas L, Clément K, Langin D.
    Diabetes; 2007 Oct 21; 56(10):2467-75. PubMed ID: 17646210
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Design, synthesis and evaluation of carbazole derivatives as PPAR alpha/gamma dual agonists and antioxidants.
    Kumar R, Ramachandran U, Srinivasan K, Ramarao P, Raichur S, Chakrabarti R.
    Bioorg Med Chem; 2005 Jul 01; 13(13):4279-90. PubMed ID: 15869880
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Effect of saponins from Helicteres isora on lipid and glucose metabolism regulating genes expression.
    Bhavsar SK, Singh S, Giri S, Jain MR, Santani DD.
    J Ethnopharmacol; 2009 Jul 30; 124(3):426-33. PubMed ID: 19505560
    [Abstract] [Full Text] [Related]

  • 56. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome.
    Kawada T, Goto T, Hirai S, Kang MS, Uemura T, Yu R, Takahashi N.
    Asia Pac J Clin Nutr; 2008 Jul 30; 17 Suppl 1():126-30. PubMed ID: 18296319
    [Abstract] [Full Text] [Related]

  • 57. Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-alpha.
    Huang TH, Peng G, Li GQ, Yamahara J, Roufogalis BD, Li Y.
    Toxicol Appl Pharmacol; 2006 Feb 01; 210(3):225-35. PubMed ID: 15975614
    [Abstract] [Full Text] [Related]

  • 58. Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients.
    Panunti B, Fonseca V.
    Vascul Pharmacol; 2006 Jul 01; 45(1):29-35. PubMed ID: 16777491
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.